BCAS1 defines a heterogeneous cell population in diffuse gliomas
Raquel Morales-Gallel1, María José Ulloa-Navas2, Patricia García-Tárraga1
1Laboratory of Comparative Neurobiology, Institute Cavanilles of Biodiversity and Evolutionary Biology, University of Valencia-CIBERNED, Valencia, Spain.
Oncotarget
|January 26, 2024
Summary
Brain enriched myelin associated protein 1 (BCAS1) marks immature oligodendrocytes, potentially originating diffuse gliomas. BCAS1+ stellate cells proliferate in oligodendrogliomas, suggesting BCAS1 as a key marker for tumor malignancy.
Area of Science:
- Neuro-oncology
- Cellular biology
- Tumorigenesis
Background:
- Immature oligodendrocytes are implicated in diffuse glioma development.
- Brain enriched myelin associated protein 1 (BCAS1) is a novel marker for immature oligodendrocytes.
- BCAS1's role in diffuse gliomas remains largely uninvestigated.
Purpose of the Study:
- To analyze BCAS1 expression in diffuse gliomas.
- To characterize the molecular and ultrastructural features of BCAS1-expressing cells.
- To investigate the potential role of BCAS1 in glioma tumorigenesis.
Main Methods:
- Immunohistochemistry and electron microscopy were used to analyze BCAS1 expression and cell morphology.
- Tumor samples from patients with oligodendrogliomas, astrocytomas, and glioblastomas were studied.
- Proliferative capacity of BCAS1-positive cells was assessed.
Main Results:
- BCAS1-positive cells exhibited stellate or spherical morphologies.
- Both cell types were found isolated in all gliomas studied.
- Proliferative BCAS1-positive stellate cells formed nodules, particularly in oligodendrogliomas.
Conclusions:
- BCAS1-positive cells, especially stellate forms, show proliferative potential in diffuse gliomas.
- The distribution and proliferation of BCAS1-positive stellate cells in oligodendrogliomas warrant further investigation.
- BCAS1 represents a promising marker for understanding diffuse glioma malignancy.
